A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma

Completed · Phase 2

Conditions studied: Glaucoma, Ocular Hypertension

In brief

The purpose of this study is to determine if the Punctal Plug Delivery System is safe and effective in controlling intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

Key facts

Study ID

NCT00820300

Run by

Mati Therapeutics Inc.

People needed

113

Starts

2009-01-01

Expected to finish

2009-12-01

Last updated by the study team

2013-09-19

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Over 18 yrs with ocular hypertension or open-angle glaucoma
• Subjects who have a best-corrected visual acuity of 20/100 or better.

You may not qualify if…

• Subjects who wear contact lenses.
• Uncontrolled medical conditions
• Subjects requiring chronic topical artificial tears, lubricants, and/or requiring any other chronic topical medications.
• Subjects who have a history of chronic or recurrent inflammatory eye disease.

Where it is running

• Study site — Menlo Park, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.